ICL - ICL Group Ltd
NYSE
->
Basic Materials
->
Agricultural Inputs
Tel Aviv,
Israel
Type: Equity
ICL price evolution
ICL
| (in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $1727 | $1793 | $1739 | $1749 |
| Inventory | $1544 | $1630 | $1703 | $1722 |
| Total current assets | $3667 | $3907 | $4034 | $3940 |
| Long term investments | ||||
| Property, plant & equipment | $6285 | $6285 | $6329 | $6125 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $11205 | $11486 | $11627 | $11274 |
| Current liabilities | ||||
| Accounts payable | $834 | $914 | $912 | $814 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $2262 | $2440 | $2638 | $2286 |
| Long term debt | $1850 | $1883 | $1829 | $1984 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $5459 | $5724 | $5859 | $5610 |
| Shareholders' equity | ||||
| Retained earnings | $5841 | $5777 | $5730 | $5714 |
| Other shareholder equity | -$621 | $5762 | -$485 | -$573 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 28 Feb 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $592 | $508 | $473 | $214 |
| Short term investments | $346 | $323 | $91 | $219 |
| Net receivables | $1393 | $1583 | $1418 | $1108 |
| Inventory | $1703 | $2134 | $1570 | $1250 |
| Total current assets | $4034 | $4548 | $3909 | $2841 |
| Long term investments | $7593 | $7202 | $26 | $225 |
| Property, plant & equipment | $6329 | $5969 | $5754 | $5550 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $6823 | |||
| Total investments | ||||
| Total assets | $11627 | $11750 | $11080 | $9664 |
| Current liabilities | ||||
| Accounts payable | $912 | $1006 | $1064 | $740 |
| Deferred revenue | ||||
| Short long term debt | $858 | $512 | $190 | $361 |
| Total current liabilities | $2638 | $2606 | $2612 | $2177 |
| Long term debt | $1829 | $2312 | $2436 | $1833 |
| Total noncurrent liabilities | $3399 | |||
| Total debt | ||||
| Total liabilities | $5859 | $6286 | $6344 | $5576 |
| Shareholders' equity | ||||
| Retained earnings | $5583 | $5385 | $4321 | $3752 |
| Other shareholder equity | -$485 | -$570 | -$306 | -$312 |
| Total shareholder equity | $5768 | $5464 | $4527 | $3930 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1735 | |||
| Cost of revenue | ||||
| Gross Profit | $557 | |||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $354 | |||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $42 | |||
| Interest expense | -$35 | |||
| Net income | ||||
| Net income | $109 | |||
| Income (for common shares) | ||||
| (in millions $) | 14 Mar 2024 | 28 Feb 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $7536 | $10015 | $6955 | $5043 |
| Cost of revenue | $4865 | $4983 | $4344 | $3553 |
| Gross Profit | $2671 | $5032 | $2611 | $1490 |
| Operating activities | ||||
| Research & development | $71 | $68 | $64 | $54 |
| Selling, general & administrative | $1353 | $1472 | $1343 | $1036 |
| Total operating expenses | $6289 | $6523 | $5745 | $4711 |
| Operating income | $1247 | $3492 | $1210 | $332 |
| Income from continuing operations | ||||
| EBIT | $1248 | $3493 | $1210 | $332 |
| Income tax expense | $287 | $1185 | $260 | $25 |
| Interest expense | -$216 | -$96 | ||
| Net income | ||||
| Net income | $647 | $2159 | $783 | $11 |
| Income (for common shares) | $647 | $2159 | $783 | $11 |
| (in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$220 | -$102 | -$863 | -$598 |
| Financing activities | ||||
| Dividends paid | -$120 | -$61 | -$474 | -$406 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$512 | -$229 | -$712 | -$673 |
| Effect of exchange rate | -$9 | -$5 | -$17 | -$19 |
| Change in cash and equivalents | -$133 | -$57 | $3 | -$110 |
| (in millions $) | 14 Mar 2024 | 28 Feb 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $647 | $2159 | $783 | $11 |
| Operating activities | ||||
| Depreciation | $536 | $498 | $490 | $482 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $1595 | $2025 | $1065 | $804 |
| Investing activities | ||||
| Capital expenditures | -$780 | -$747 | -$611 | -$626 |
| Investments | ||||
| Total cash flows from investing | -$863 | -$754 | -$579 | -$583 |
| Financing activities | ||||
| Dividends paid | -$276 | -$118 | ||
| Sale and purchase of stock | ||||
| Net borrowings | $1749 | $1993 | $52 | -$10 |
| Total cash flows from financing | -$712 | -$1303 | -$244 | -$105 |
| Effect of exchange rate | $17 | $3 | ||
| Change in cash and equivalents | $84 | -$56 | $259 | $119 |
News
Fundamentals
| Market cap | $7.28B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 1.29B |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.02 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.62 |
| Quick ratio | 0.94 |